CME Group Inc.
CME
$262.22
$0.370.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.70B | 5.64B | 5.41B | 5.27B | 5.25B |
| Total Other Revenue | 421.90M | 398.20M | 373.80M | 345.00M | 316.90M |
| Total Revenue | 6.12B | 6.03B | 5.79B | 5.62B | 5.57B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.12B | 6.03B | 5.79B | 5.62B | 5.57B |
| SG&A Expenses | 1.65B | 1.63B | 1.59B | 1.58B | 1.57B |
| Depreciation & Amortization | 336.80M | 339.70M | 344.10M | 349.20M | 352.60M |
| Other Operating Expenses | 200.80M | 194.10M | 187.20M | 185.50M | 188.20M |
| Total Operating Expenses | 2.18B | 2.16B | 2.12B | 2.11B | 2.11B |
| Operating Income | 3.94B | 3.87B | 3.67B | 3.50B | 3.46B |
| Income Before Tax | 4.54B | 4.45B | 4.25B | 4.11B | 4.15B |
| Income Tax Expenses | 1.02B | 985.00M | 945.00M | 912.50M | 927.40M |
| Earnings from Continuing Operations | 3.53K | 3.47K | 3.30K | 3.20K | 3.23K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.53B | 3.47B | 3.30B | 3.20B | 3.23B |
| EBIT | 3.94B | 3.87B | 3.67B | 3.50B | 3.46B |
| EBITDA | 4.27B | 4.21B | 4.01B | 3.85B | 3.81B |
| EPS Basic | 9.69 | 9.52 | 9.08 | 8.79 | 8.87 |
| Normalized Basic EPS | 7.88 | 7.74 | 7.39 | 7.15 | 7.23 |
| EPS Diluted | 9.67 | 9.51 | 9.07 | 8.79 | 8.87 |
| Normalized Diluted EPS | 7.87 | 7.73 | 7.38 | 7.14 | 7.22 |
| Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Average Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Dividend Per Share | 4.60 | 4.55 | 4.50 | 4.45 | 4.40 |
| Payout Ratio | 101.66% | 102.88% | 107.38% | 110.34% | 100.29% |
